60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026

60 Degrees Pharma reached minimum enrollment for interim analysis of its hospitalized babesiosis trial, with data expected by October 6, 2026....